Yang, Guangjian
Tian, Linyan
He, Dongsheng
Hu, Jiaqi
Wei, Fang
Li, Weihua
Li, Pei
Qiu, Huanbing
Tang, Xiaoyong https://orcid.org/0000-0002-4176-5232
Wang, Yan https://orcid.org/0000-0002-1743-6383
Article History
Received: 23 January 2026
Accepted: 29 April 2026
First Online: 4 May 2026
Declarations
:
: This study was conducted in accordance with the guidelines of the 1964 Declaration of Helsinki. It was approved by the Ethics Committee of National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (Approval No. 18–070/1678). The requirement for obtaining informed consent was waived owing to the retrospective, and observational nature of this study.
: Not applicable.
: Author Jiaqi Hu is employed by PharmaBlock Sciences (Nanjing) Inc., and the remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.